Artiva Biotherapeutics Inc (ARTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -83,865 | -63,093 | -41,565 | -20,311 | -65,373 |
| Depreciation Amortization | 2,597 | 1,931 | 1,269 | 628 | 2,431 |
| Accounts receivable | N/A | N/A | N/A | N/A | 1,034 |
| Accounts payable and accrued liabilities | -760 | -610 | -168 | 41 | 519 |
| Other Working Capital | -424 | -4,506 | -4,897 | -1,487 | -325 |
| Other Operating Activity | 5,701 | 4,253 | 2,537 | 1,288 | 6,682 |
| Operating Cash Flow | $-76,751 | $-62,025 | $-42,824 | $-19,841 | $-55,032 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 65,998 | 49,537 | 32,659 | 10,482 | -119,821 |
| PPE Investments | -2,587 | -2,166 | -1,566 | -511 | -642 |
| Investing Cash Flow | $63,411 | $47,371 | $31,093 | $9,971 | $-120,463 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -132 | -98 | -66 | -33 | -149 |
| Common Stock Issued | 371 | 371 | 272 | 272 | 166,558 |
| Other Financing Activity | -230 | -143 | -39 | 0 | -4,183 |
| Financing Cash Flow | $9 | $130 | $167 | $239 | $162,226 |
| Beginning Cash Position | 40,493 | 40,493 | 40,493 | 40,493 | 53,762 |
| End Cash Position | 27,162 | 25,969 | 28,929 | 30,862 | 40,493 |
| Net Cash Flow | $-13,331 | $-14,524 | $-11,564 | $-9,631 | $-13,269 |
| Free Cash Flow | |||||
| Operating Cash Flow | -76,751 | -62,025 | -42,824 | -19,841 | -55,032 |
| Capital Expenditure | -2,587 | -2,166 | -1,566 | -511 | -642 |
| Free Cash Flow | -79,338 | -64,191 | -44,390 | -20,352 | -55,674 |